Insulatard

Insulatard

insulin isophane, human

Manufacturer:

Novo Nordisk

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Isophane insulin, rDNA
Dosage/Direction for Use
SC Individualized dosage ranging from 0.3-1 IU/kg daily.
Contraindications
Special Precautions
Not to administered IV & not to be used in insulin pumps. Inadequate dosing or discontinuation of treatment especially in type 1 DM. Concomitant illness, infections & feverish conditions. Diseases affecting adrenal, pituitary or thyroid gland. Physical activity or diet changes. Diabetic ketoacidosis, hypoglycaemia, longstanding diabetes. Transferring to another type of insulin. Lipodystrophy, inj site reactions. Combination w/ thiazolidinediones in CHF patients. May affect ability to drive & use machines. Renal & hepatic diseases. Intensified blood glucose control & monitoring during pregnancy. Dosage or diet adjustment during lactation.
Adverse Reactions
Hypoglycaemia. Urticaria, rash; diabetic retinopathy; lipodystrophy; inj site reactions; oedema.
Drug Interactions
Reduced insulin requirement w/ oral antidiabetics, MAOIs, non-selective β-blockers, ACE inhibitors, salicylates, anabolic steroids, sulphonamides. Increased insulin requirement w/ OCs, thiazides, glucocorticoids, thyroid hormones, sympathomimetics, growth hormone, danazol. Masked hypoglycaemia symptoms & delayed recovery from hypoglycaemia by β-blockers. Increased or decreased insulin requirement w/ octreotide/lanreotide. Intensified or reduced insulin hypoglycaemic effect by alcohol.
ATC Classification
A10AC01 - insulin (human) ; Belongs to the class of intermediate-acting insulins and analogues. Used in the treatment of diabetes.
Presentation/Packing
Form
Insulatard FlexPen 100 IU/mL
Packing/Price
3 mL x 5 × 1's
Form
Insulatard penfill for Inj 100 IU/mL
Packing/Price
3 mL x 5 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in